By Dominic Bernard2026-04-29T06:25:00
Source: Haleon
The Sensodyne owner registered organic growth of 2.2% to reach £2.9bn in revenues in the three months to 31 March 2026
Organic first quarter revenue growth of 8.3% in Haleon’s oral health division has helped the group through a weak cold and flu season.
Already have an account? Sign in here
Already have an account? Sign in here